Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-18-042495

Co-Chief Executive Officer gave up 541 shares (to pay taxes)

  • Co-Chief Executive Officer acquired 1,562 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEST MICHAEL D Co-Chief Executive Officer 2018-07-10 Option exercise +1,562 887,299 D: show line 1 in the form
WEST MICHAEL D Co-Chief Executive Officer 2018-07-10 Shares withheld for taxes −541 $2.20 $1,190 886,758 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
WEST MICHAEL D Co-Chief Executive Officer 2018-07-10 Option exercise · Restricted Stock Units −1,562 10,938 D: show line 3 in the form
Loading xslF345X03/doc4.xml…